Mazen Hanna, MD, M.D
Rare Disease / Clinical Research
The Cleveland Clinic
CLEVELAND, OH
QC-verified· March 2026 PI on 1 trialNPI: 1033128731
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Clinical trials (1)
Verify independently
Other specialists for Wild type ATTR amyloidosis
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Adalgisa Condoluci, MDOncology Institute of Southern Switzerland
- Mathew S Maurer, MDColumbia University
- John L Berk, M.D., D.D.SBoston UniversityCA
- Torstein Hole, MD, PhDHelse Møre og Romsdal HF and NTNU
- Nicolas Verheyen, Res Prof, MD PhDMedical University of Graz
- Jeff Packman, MBAFoldRx Pharmaceuticals, Inc
- MARK MCGOVERN, RNEidos Therapeutics, a BridgeBio company
- Thibaud DAMY, MD PhDCHU Henri Mondor, Paris